Metraipolis › archive › dc_dadad3f54aa2
Stroke minimization through additive anti-atherosclerotic agents in routine treatment (SMAART) II: Rationale for a multi-country polypill phase 3 trial in… — Europe PMC PMID:41727852
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41727852
- DOI
- 10.1016/j.neuros.2026.100020
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T14:39:09.918Z
- SHA-256 of the archived text
3061e84df4179a4ec68d6f80dee6eed6c414f1fd6137b0d74b218bace4ce5cc9- Stable URL of this page
https://metraipolis.com/documento/dc_dadad3f54aa2
How to cite
Stroke minimization through additive anti-atherosclerotic agents in routine treatment (SMAART) II: Rationale for a multi-country polypill phase 3 trial in… — Europe PMC PMID:41727852 — Europe PMC (en), https://europepmc.org/article/MED/41727852 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dadad3f54aa2 (Metraipolis archive dc_dadad3f54aa2, sha256 3061e84df4179a4ec68d6f80dee6eed6c414f1fd6137b0d74b218bace4ce5cc9)
BibTeX
@misc{dcdadad3f54aa2,
title = {Stroke minimization through additive anti-atherosclerotic agents in routine treatment (SMAART) II: Rationale for a multi-country polypill phase 3 trial in… — Europe PMC PMID:41727852},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41727852},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dadad3f54aa2; sha256 3061e84df4179a4ec68d6f80dee6eed6c414f1fd6137b0d74b218bace4ce5cc9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41727852. Agents can read the archived copy with the MCP tool read_document.